Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2025
Misclassification Matters: A Case for Utilization of Histologic Coding in UK Biobank AnalysesMichael A O'Rorke, Isaac R Werner, Bradley D McDowell, et al.
Journal of Medical Virology|December 19, 2015
HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern IrelandLesley A Anderson, Michael A O'Rorke, Robbie Wilson, et al.
International Journal of Cancer|October 27, 2009
Can physical activity modulate pancreatic cancer risk? a systematic review and meta-analysisMichael A O'Rorke, Marie M Cantwell, Chris R Cardwell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2025
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from The All of Us Research ProgramTao Xu, Joseph S Dillon, Dawn E Quelle, et al.
International Journal of Cancer|January 21, 2012
Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR studyMichael A O'Rorke, Marie M Cantwell, Christian C Abnet, et al.
Leukemia & Lymphoma|June 26, 2025
Changes in first-line treatment patterns according to frailty in chronic lymphocytic leukemia/small lymphocytic lymphomaVanessa E Slater, Ryan M Carnahan, Christopher S Strouse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2014
Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic reviewCharlene M McShane, Liam J Murray, Ola Landgren, et al.
American Journal of Clinical Oncology|August 3, 2021
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer PatientsKristin S Weeks, Charles F Lynch, Michele M West, et al.
Journal of Cancer Research and Clinical Oncology|November 3, 2024
Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centersTao Xu, Joseph S Dillon, Mary A Maluccio, et al.
Journal of the American Heart Association|December 1, 2022
Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare StudyEmma Herbach, Michael A O'Rorke, Ryan M Carnahan, et al.
Pageof 2